GMP manufacturing
Recipharm's multi-purpose plant can manufacture several API products at a time, including generic and hormonal APIs. The facility is equipped to handle high pressure reactions as well as high temperature (up to 150 degrees Celsius) and low temperature (down to –80 degrees Celsius) reactions. We also offer a number of different batch sizes ranging from 20L to 6000L, supporting early development and commercial needs.
Our development facilities have excellent track records in medicinal chemistry and can carry out exploratory work, optimisation and up-scaling of early syntheses.
Recipharm also runs a dedicated beta-lactam plant for the lyophilisation of bulk APIs.
Available APIs
| Products | Regulatory |
|---|---|
| Blonanserin | EU-DMF / J-DMF |
| Clenbuterol HCl | EU-DMF / CoS |
| Dex-Medetomidine HCl** | EU-DMF / US-DMF |
| Erdosteine | EU-DMF / K-DMF |
| Glimepiride | EU-DMF / CoS |
| Indapamide | EU-DMF / CoS |
| Levobupivacaine HCl** | EU-DMF |
| Lornoxicam* | EU-DMF |
| Lurasidone HCl | US-DMF |
| Midodrine HCl | EU-DMF / US-DMF / J-DMF |
| Nicorandil | EU-DMF |
| Prednicarbate | EU-DMF – CoS |
| Procaterol HCl Hemihydrate | EU-DMF / J-DMF |
| Ropivacaine HCl Monohydrate** | EU-DMF / CoS |
| Tenoxicam* | EU-DMF / CoS / J-DMF |
| Tirofiban base** | EU-DMF |
| Tirofiban HCl** | EU-DMF |
| Tulobuterol | EU-DMF / US-DMF / J-DMF |
| Urapidil* | EU-DMF |
* Oral & injectable grades
** Injectable grade
N.B. Products are not offered in countries where valid patents exist. The final responsibility with respect to third party patent rights in a specific country lies exclusively with the user. Products under development are supplied for R&D purposes only and in compliance with Italian law and as permitted under 35 USC 271.